News for Charles River Laboratories Stock (CRL)

Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration

Business Wire • 11/28/23

Charles River Laboratories to Present at Evercore ISI Investor Conference

Business Wire • 11/27/23

Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation

Seeking Alpha • 11/26/23

The 3 Most Undervalued Tech Stocks to Buy Now: November 2023

InvestorPlace • 11/17/23

Charles River (CRL) Widens CliniPrime GMP Suite With New Launch

Zacks Investment Research • 11/17/23

Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products

Business Wire • 11/16/23

Charles River (CRL) to Advance AI Drug Discovery With New Pact

Zacks Investment Research • 11/14/23

Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology

PRNewsWire • 11/13/23

Charles River Laboratories' Industry Experts to Present Advanced Modalities at Neuroscience 2023

Business Wire • 11/09/23

Charles River's (CRL) Q3 Earnings Beat, Margins Decline

Zacks Investment Research • 11/08/23

Charles River Laboratories International, Inc. (CRL) Q3 2023 Earnings Call Transcript

Seeking Alpha • 11/08/23

Charles River (CRL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research • 11/08/23

Charles River beats quarterly profit estimates, trims full-year revenue growth

Reuters • 11/08/23

Charles River Laboratories Announces Third-Quarter 2023 Results

Business Wire • 11/08/23

Unlocking Q3 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research • 11/06/23

Consulting firm Charles River raises dividend to boost yield above the S&P 500's, while profit and revenue miss expectations

Market Watch • 11/02/23

Earnings Preview: Charles River Laboratories (CRL) Q3 Earnings Expected to Decline

Zacks Investment Research • 11/01/23

Charles River (CRL) to Report Q3 Earnings: What's in Store?

Zacks Investment Research • 11/01/23

Why Charles River (CRL) Could Beat Earnings Estimates Again

Zacks Investment Research • 10/24/23

Charles River (CRL) Offers Access to Preclinical Cancer Research

Zacks Investment Research • 10/23/23

Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business

Business Wire • 10/19/23

Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call

Business Wire • 10/16/23

Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research

Business Wire • 10/16/23

Multiply Labs Collaborates with Industry Leaders University of California San Francisco, Cytiva, Thermo Fisher Scientific and Charles River to Deliver a Successful Proof-of-Concept of Robotic Cell Therapy Manufacturing

Business Wire • 10/11/23

Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals

Business Wire • 10/11/23